Wednesday's session will see investors focus on central banks.
Uber Technologies swung to a profit in the third quarter, the ride hailing and delivery app confirmed on Tuesday, on the back of strong demand.
US stocks rose for a seventh straight day on Tuesday as both oil prices and bond yields dropped.
London markets had a mixed performance on Tuesday, influenced by factors including uninspiring Chinese trade figures, the latest UK house price and retail sales data, and a barrage of corporate news.
Artificial intelligence software and simulation specialist Intelligent Ultrasound announced a research agreement with the University of Dundee on Tuesday to advance the development of AI-based tools for screening patients with liver disease.
Galileo Resources updated the market on its second-phase diamond drilling programme at the Shinganda copper-gold project in Zambia on Tuesday.
Harland & Wolff Group announced the successful award of a contract valued at $1. 5m for its newly established Miami office on Tuesday.
Futura Medical expands licensing agreement with M8 Pharmaceuticals
Sexual health-focused pharmaceutical company Futura Medical announced a significant expansion of its licensing agreement with M8 Pharmaceuticals on Tuesday.
Cybersecurity software company Intercede Group announced a series of significant contract and renewal orders on Tuesday.
Wall Street trading got off to a mixed start on Tuesday as traders look ahead to tomorrow's speech from Federal Reserve chairman Jerome Powell.
Billing, charging and customer relationship management software specialist Cerillion announced a significant advancement in its flagship product suite, Cerillion 23. 2, on Tuesday.
London’s FTSE 100 was flat at 7,420. 37in afternoon trade on Tuesday.
Accounting giant PricewaterhouseCoopers will cut approximately 600 UK-based roles, a move that comes hot on the heels of similar moves by fellow "Big Four" firms KPMG and Deloitte.
Customer experience software specialist DotDigital Group reported a 10% uplift in group revenue in its final results on Tuesday, reaching £69. 2m.
Bank of America Merrill Lynch reinstated coverage of GSK spinoff Haleon on Tuesday, with a ‘buy’ rating and 390p price target.
Jefferies downgraded Hikma Pharmaceuticals on Tuesday to ‘hold’ from ‘buy’ and cut the price target to 1,940p from 2,125p.
Industrial and electrical products distributor RS Group revealed on Tuesday that revenues had declined in the six months ended 30 September.
US futures were pointing to modest losses ahead of the bell on Tuesday as major indices look set to halt their recent rally.
Insurance company Direct Line said on Tuesday that gross written premiums had grown in the three months ended 30 September, driven by premium rate increases and the commencement of its Motability partnership.
Housebuilder Vistry has signed a £819. 0m deal with Leaf Living and Sage Homes for the delivery of more than 2,900 mixed-tenure new homes.
Important Legal Notice about News Sources: Pilling and Co Stockbrokers Ltd. is not responsible for the content or accuracy of third party news and we may not share the views of the author or publisher. We provide third party news for your convenience and information only and make no representation or endorsement whatsoever and hereby exclude all liability for any loss or damage that may be incurred by you as a result of your access or use. Please note that third party content may be subject to terms and conditions imposed by the third party owner of that content.
The value of investments can fall and you may get back less than you invested.